{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:56:40Z","timestamp":1790402200951,"version":"4.1.0"},"reference-count":23,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1976,8]]},"abstract":"<jats:p>The pathophysiology of Gilbert's syndrome was studied by investigating the metabolism of the drug tolbutamide, which is metabolised by the liver but does not undergo glucuronidation. Using rat liver cell supernatant, tolbutamide was shown to bind to the hepatic cytoplasmic Y protein in a manner similar to other organic anions, but not to Z protein. In 31 patients with Gilbert's syndrome the plasma disappearance (plasma half-life, mean +\/- SD: 628+\/-84 min) and metabolic clearance (7-9+\/-1-8 ml\/min) were significantly (P less than 0-0005) altered compared with the 13 controls (mean half-life 393+\/-26 and mean clearance 13-4+\/-1-5). The eight patients with hyperbilirubinaemia due to haemolytic disease showed no difference from the normal control subjects. In three patients with Gilbert's syndrome the cumulative urinary excretion of tolbutamide metabolites, 24 hours after the administration of the drug, was 30% lower than in the controls. In the five patients with Gilbert's syndrome, phenobarbital administration (100 mg\/day) produced a significant increase in clearance of the drug from 8-8+\/-0-8 to 13-4+\/-1-9 ml\/min; this was paralleled by a fall in serum bilirubin concentration. The plasma half-life of tolbutamide was similar in Gunn rats and Wistar rats. The results suggest that the metabolic defect(s) of Gilbert's syndrome affects compounds other than bilirubin and that defective uptake is probably the major factor.<\/jats:p>","DOI":"10.1136\/gut.17.8.581","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"581-587","source":"Crossref","is-referenced-by-count":42,"title":["Alteration of drug metabolism in Gilbert's syndrome."],"prefix":"10.1136","volume":"17","author":[{"given":"N","family":"Carulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ponz de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Manenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1976,8,1]]},"reference":[{"key":"ref_1","first-page":"59","article-title":"Defects in hepatic uptake and transport and biliary excretion of estrogens","volume":"2","author":"Adlercreutz, H.; Tikkanen, M.J.","year":"1973","unstructured":"Adlercreutz, H., and Tikkanen, M. J. (1973). Defects in hepatic uptake and transport and biliary excretion of estrogens. Medecine et Chirugie Digestives, 2, 59-65.","journal-title":"Medecine et Chirugie Digestives"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.me.17.020166.001353","article-title":"Hepatic aspects of bilirubin metabolism","volume":"17","author":"Arias, I.M.","year":"1966","unstructured":"Arias, I. M. (1966). Hepatic aspects of bilirubin metabolism. Annual Review of Medicine, 17, 257-274.","journal-title":"Annual Review of Medicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0016-5085(19)33296-2","article-title":"Defective bromosulfophtale in clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome)","volume":"63","author":"Berk, P.D.; Blaschke, T.F.; Waggoner, J.G.","year":"1972","unstructured":"Berk, P. D., Blaschke, T. F., and Waggoner, J. G. (1972). Defective bromosulfophtale in clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome). Gastroenterology, 63, 472-481.","journal-title":"Gastroenterology"},{"key":"ref_4","first-page":"296","article-title":"Constitutional hepatic dysfunction (Gilbert's syndrome). A new definition based on kinetic studies with unconjugated radiobilirubin","volume":"49","author":"Berk, P.D.; Bloomer, J.R.; Hoew, R.B.; Berlin, N.I.","year":"1970","unstructured":"Berk, P. D., Bloomer, J. R., Hoew, R. B., and Berlin, N. I. (1970). Constitutional hepatic dysfunction (Gilbert's syndrome). A new definition based on kinetic studies with unconjugated radiobilirubin. American JournalofMedicine, 49, 296-305.","journal-title":"American JournalofMedicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1152\/ajplegacy.1970.219.3.809","article-title":"Mechanism of phenobarbital-induced hypercholeresis in the rat","volume":"219","author":"Berthelot, P.; Erlinger, S.; Dhumeaux, D.; Preaux, A.-M.","year":"1970","unstructured":"Berthelot, P., Erlinger, S., Dhumeaux, D., and Preaux, A-M. (1970). Mechanism of phenobarbital-induced hypercholeresis in the rat. American Journal of Physiology, 219, 809-813.","journal-title":"American Journal of Physiology"},{"key":"ref_6","author":"Billing, B.H.; Williams, R.; Richards, T.G.","year":"1964","unstructured":"Billing, B. H., Williams, R., and Richards, T. G. (1964)."},{"key":"ref_7","article-title":"Hepatic bilirubin UDP-","author":"Black, M.; Billing, B.H.","year":"1969","unstructured":"Black, M., and Billing, B. H. (1969). Hepatic bilirubin UDP-"},{"key":"ref_8","first-page":"12661271","article-title":"glucuronyl transferase activity in liver disease and Gilbert's syndrome","volume":"280","unstructured":"glucuronyl transferase activity in liver disease and Gilbert's syndrome. New England Journal of Medicine, 280, 12661271.","journal-title":"New England Journal of Medicine"},{"key":"ref_9","first-page":"1","article-title":"Effect of phenobarbitone on plasma [14C] bilirubin clearance in patients with unconjugated hyperbilirubinaemia","volume":"46","author":"Black, M.; Fevery, J.; Parker, D.; Jacobson, J.; Billing, B.H.; Carson, E.R.","year":"1974","unstructured":"Black, M., Fevery, J., Parker, D., Jacobson, J., Billing, B. H., and Carson, E. R. (1974). Effect of phenobarbitone on plasma [14C] bilirubin clearance in patients with unconjugated hyperbilirubinaemia. Clinical Science and Molecular Medicine, 46, 1-17.","journal-title":"Clinical Science and Molecular Medicine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0003-2697(60)90025-7","article-title":"A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counter","volume":"1","author":"Bray, G.A.","year":"1960","unstructured":"Bray, G. A. (1960). A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counter. Annals ofBiochemistry, 1, 279-285.","journal-title":"Annals ofBiochemistry"},{"key":"ref_11","first-page":"317","article-title":"Pharmacological implications of microsomal enzyme induction","volume":"19","author":"Conney, A.H.","year":"1967","unstructured":"Conney, A. H. (1967). Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews, 19, 317-366.","journal-title":"Pharmacological Reviews"},{"key":"ref_12","author":"Darby, F.J.; Grundy, R.K.; P-Evans, D.A.","year":"1972","unstructured":"Darby, F. J., Grundy, R. K., and P-Evans, D. A. (1972)."},{"key":"ref_13","first-page":"829","article-title":"Hepatic bilirubin glucuronidation in Gilbert's syndrome","volume":"81","author":"Felsher, B.F.; Craig, J.R.; Carpio, N.","year":"1973","unstructured":"Felsher, B. F., Craig, J. R., and Carpio, N. (1973). Hepatic bilirubin glucuronidation in Gilbert's syndrome. Journal of Laboratory and Clinical Medicine, 81, 829-837.","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"ref_14","first-page":"314","article-title":"The involvement of cytoplasmic BSP binding proteins in Gilbert's syndrome","volume":"10","author":"Frezza, M.; Tiribelli, C.","year":"1974","unstructured":"Frezza, M., and Tiribelli, C. (1974). The involvement of cytoplasmic BSP binding proteins in Gilbert's syndrome. Digestion, 10, 314-315.","journal-title":"Digestion"},{"key":"ref_15","first-page":"48","article-title":"Two hepatic cytoplasmic protein fractions Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophtalein, and other anions. Journalof ClinicalInvestigation","author":"Levi, A.J.; Gatmaitan, Z.; Arias, I.M.","year":"1969","unstructured":"Levi, A. J., Gatmaitan, Z., and Arias, I. M. (1969). Two hepatic cytoplasmic protein fractions Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophtalein, and other anions.Journalof ClinicalInvestigation, 48,2156-2167."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/gut.16.3.220","article-title":"Liver ultrastructure in Gilbert's syndrome","volume":"16","author":"McGee, J.O.'D.; Allan, J.G.; Russel, R.I.; Patrick, R.S.","year":"1975","unstructured":"McGee, J. O'D., Allan, J. G., Russel, R. I., and Patrick, R. S. (1975). Liver ultrastructure in Gilbert's syndrome. Gut, 16, 220-224.","journal-title":"Gut"},{"key":"ref_17","first-page":"132","article-title":"Kinetics ofcarboxytolbutamide excretion following tolbutamide and carboxytolbutamide administration","author":"Nelson, E.; O'Reilly, I.","year":"1961","unstructured":"Nelson, E., and O'Reilly, I. (1961). Kinetics ofcarboxytolbutamide excretion following tolbutamide and carboxytolbutamide administration. Journal of Pharmacology and Experimental Therapeutics, 132,103-109.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref_18","author":"Nistrup Madsen, S.; Fog-Moller, F.; Persson, I.","year":"1971","unstructured":"Nistrup Madsen, S., Fog-Moller, F., and Persson, I. (1971)."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0014-2999(71)90229-9","article-title":"Distribution of tolbutamide and chlorpropamide after administration to non-diabetic rats","volume":"13","unstructured":"Distribution of tolbutamide and chlorpropamide after administration to non-diabetic rats. European Journal of Pharmacology, 13, 374-380.","journal-title":"European Journal of Pharmacology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1172\/JCI106721","article-title":"Studies of Y and Z, two hepatic cytoplasmic organic anion-binding proteins: effect of drugs, chemicals, hormones and cholestasis","volume":"50","author":"Reyes, H.; Levi, A.J.; Gatmaitan, Z.; Arias, I.M.","year":"1971","unstructured":"Reyes, H., Levi, A. J., Gatmaitan, Z., and Arias, I. M. (1971). Studies of Y and Z, two hepatic cytoplasmic organic anion-binding proteins: effect of drugs, chemicals, hormones and cholestasis. Journal of Clinical Investigation, 50, 2242-2251.","journal-title":"Journal of Clinical Investigation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF01480893","article-title":"tYber eine M8glichkeit zur colorimetrischen Bestimmung von N-(4-methyl-benzolsulfonyl) -N'butyl Harnstoff in Serum","volume":"35","author":"Spingler, H.","year":"1957","unstructured":"Spingler, H. (1957). tYber eine M8glichkeit zur colorimetrischen Bestimmung von N-(4-methyl-benzolsulfonyl) -N'butyl Harnstoff in Serum. Klinische Wochenschrift, 35, 533-535.","journal-title":"Klinische Wochenschrift"},{"key":"ref_22","author":"Tagg, J.; Yasuda, D.M.; Tanabe, M.; Mitoma, C.","year":"1967","unstructured":"Tagg, J., Yasuda, D. M., Tanabe, M., and Mitoma, C. (1967."},{"key":"ref_23","article-title":"The metabolic fate of tolbutamide in man and in the rat","author":"Thomas, R.C.; Ikeda, G.J.","year":"1966","unstructured":"Thomas, R. C., and Ikeda, G. J. (1966). The metabolic fate of tolbutamide in man and in the rat. Journal of Medical","journal-title":"Journal of Medical"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.17.8.581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T10:56:35Z","timestamp":1765623395000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.17.8.581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1976,8]]},"references-count":23,"journal-issue":{"issue":"8","published-online":{"date-parts":[[1976,8,1]]},"published-print":{"date-parts":[[1976,8]]}},"alternative-id":["10.1136\/gut.17.8.581"],"URL":"https:\/\/doi.org\/10.1136\/gut.17.8.581","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1976,8]]}}}